Zentalis Pharmaceuticals Inc
NASDAQ:ZNTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zentalis Pharmaceuticals Inc
NASDAQ:ZNTL
|
US |
|
F
|
Fifth Third Bancorp
XMUN:FFH
|
US |
|
Dollarama Inc
TSX:DOL
|
CA |
|
I
|
Insperity Inc
SWB:ASF
|
US |
|
M
|
Mega Lifesciences PCL
SET:MEGA
|
TH |
|
Vinci Partners Investments Ltd
NASDAQ:VINP
|
BR |
|
Commerzbank AG
XETRA:CBK
|
DE |
|
M
|
Mondelez International Inc
SGO:MDLZ
|
US |
|
A
|
Apogee Therapeutics Inc
NASDAQ:APGE
|
US |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
|
K
|
Kawasaki Kisen Kaisha Ltd
TSE:9107
|
JP |
Intrinsic Value
The intrinsic value for Zentalis Pharmaceuticals Inc (ZNTL) under the Base Case is hidden
USD.
Compared with the current market price of 4.05 USD, the stock appears hidden
.
ZNTL looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if ZNTL is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Zentalis Pharmaceuticals Inc.
The intrinsic value for Zentalis Pharmaceuticals Inc (ZNTL) under the Base Case is hidden USD.
Compared with the current market price of 4.05 USD, the stock appears hidden.
